Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Oldach, MD
Melinta Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
119 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
La Plata, Buenos Aires, Argentina
- Facility name not stated
Loma Hermosa, Buenos Aires, Argentina
- Facility name not stated
Tandil, Buenos Aires, Argentina
- Facility name not stated
Córdoba, Córdoba Province, Argentina
- Facility name not stated
Rosario, Santa Fe Province, Argentina
- Facility name not stated
Santa Fe, Santa Fe Province, Argentina
- Facility name not stated
San Miguel de Tucumán, Tucumán Province, Argentina
- Facility name not stated
Buenos Aires, Argentina
- Facility name not stated
Buenos Aires, Argentina
- Facility name not stated
Caba, Argentina
- Facility name not stated
Pernik, Bulgaria, Bulgaria
- Facility name not stated
Rousse, Bulgaria, Bulgaria
- Facility name not stated
Sofia, Bulgaria, Bulgaria
- Facility name not stated
Sofia, Bulgaria, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Edmonton, Alberta, Canada
- Facility name not stated
Vancouver, British Columbia, Canada
- Facility name not stated
Cornwall, Ontario, Canada
- Facility name not stated
Montreal, Quebec, Canada
- Facility name not stated
Beroun, Czechia
- Facility name not stated
Santo Domingo, Dominican Republic
- Facility name not stated
Santo Domingo, Dominican Republic
- Facility name not stated
Guayaquil, Guayas, Ecuador
- Facility name not stated
Guayaquil, Ecuador
- Facility name not stated
Quito, Ecuador
- Facility name not stated
Tallinn, Estonia
- Facility name not stated
Tallinn, Estonia
- Facility name not stated
Tartu, Estonia
- Facility name not stated
Hofheim, De-he, Germany
- Facility name not stated
Rotenburg (Wümme), De-ni, Germany
- Facility name not stated
Hanover, Germany
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Budapest, Hungary
- Facility name not stated
Kecskemét, Hungary
- Facility name not stated
Nyíregyháza, Hungary
- Facility name not stated
Daugavpils, Latvia
- Facility name not stated
Liepāja, Latvia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2012
- Primary completion
- 31 Oct 2014
- Completion
- 31 Oct 2014
- Last update posted
- 3 Mar 2017
- Registered enrollment
- 860
- Registry id
- NCT01756339
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.